C07C 217/88
The oxygen atom of at least one of the etherified hydroxy groups
Official title: the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C217/88 (The oxygen atom of at least one of the etherified hydroxy groups) appears on 62 US grants and 41 published applications in this corpus.
Search patents in C07C- Granted patents
- 62
- Published applications
- 41
- Assignees
- 22
- Inventors
- 94
- Latest grant
- 30 Aug 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 12 | 6 |
| 2003 | 5 | 20 |
| 2004 | 21 | 2 |
| 2005 | 1 | 4 |
| 2006 | 3 | 2 |
| 2007 | 2 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compounds for treatment of cardiac arrhythmias and heart failure30 Aug 2022US 11,427,542 B2Elex Biotech, Inc.
- ROR-gamma modulators and uses thereof10 Aug 2021US 11,084,784 B2Piramal Enterprises Limited
- Substituted p-diaminobenzene derivatives15 Mar 2011US 7,906,537 B2H. Lundbeck A.S.
- Diamine and polyamic acid derived therefrom for liquid crystal orientation applications21 Sep 2010US 7,799,950 B2Daily Polymer Co., Ltd.
- (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity20 Apr 2010US 7,700,658 B2Pfizer Inc.
- Novel compound, and composition for forming hole transporting layer for perovskite solar cells14 Oct 2021US 2021/0319957 A1Tokyo Chemical Industry Co., Ltd.
- Compounds for treatment of cardiac arrhythmias and heart failure13 May 2021US 2021/0139429 A1Elex Biotech, Inc.
- Ror-gamma modulators and uses thereof2 Aug 2018US 2018/0215707 A1Piramal Enterprises Limited
- (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity18 Jun 2009US 2009/0156685 A1Pfizer Inc.
- Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs19 Feb 2009US 2009/0048255 A1
Most cited
By later US patents
- Reactive compounds containing perfluorocyclobutane rings72US 5,021,602 AThe Dow Chemical Company · 1991
- Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group33US 5,698,711 ARhone-Poulenc Rorer S.A. · 1997
- Reactive compounds containing perfluorocyclobutane rings27US 5,210,265 AThe Dow Chemical Company · 1993
- Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group27US 5,935,978 ARhone-Poulenc Rorer S.A. · 1999
- Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- o r25US 5,840,724 ARhone-Poulenc Rorer S.A. · 1998